ABT:NYE-Abbott Laboratories (USD)

COMMON STOCK | Medical Devices | NYE

Last Closing Price

USD 106.97

Change

-2.11 (-1.93)%

Market Cap

USD 190.99B

Volume

3.45M

Avg Analyst Target

USD 142.15 (+32.89%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict


ABT Stock Forecast & Price:
Based on the Abbott Laboratories stock forecasts from 10 analysts, the average analyst target price for Abbott Laboratories is USD 142.15 over the next 12 months. Abbott Laboratories’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Abbott Laboratories is Bullish , which is based on 11 positive signals and 4 negative signals. At the last closing, Abbott Laboratories’s stock price was USD 106.97. Abbott Laboratories’s stock price has changed by +2.45% over the past week, -8.33% over the past month and -7.55% over the last year.

About Abbott Laboratories (ABT:NYE)

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pha ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-06-28 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
MDT Medtronic PLC

-1.27 (-1.40%)

USD120.06B 24.19 15.07
SYK Stryker Corporation

-5.33 (-2.62%)

USD77.31B 38.87 23.79
EW Edwards Lifesciences Corp

-2.08 (-2.15%)

USD60.30B 39.91 28.58
BSX Boston Scientific Corp

-0.32 (-0.85%)

USD54.35B 71.74 24.08
ZBH Zimmer Biomet Holdings Inc

-2.03 (-1.87%)

USD22.82B 104.78 17.45
STE STERIS plc

-3.25 (-1.56%)

USD20.81B 83.83 23.47
PHG Koninklijke Philips NV ADR

-0.70 (-3.18%)

USD18.86B 5.94 42.94
BIO Bio-Rad Laboratories Inc

-12.53 (-2.47%)

USD14.68B 3.61 2.64
BIO-B Bio-Rad Laboratories Inc

N/A

USD14.09B 3.59 2.64
SNN Smith & Nephew SNATS Inc

-0.48 (-1.69%)

USD12.59B 24.03 11.43

ETFs Containing ABT

Symbol Name Weight Mer Price(Change) Market Cap
BTAL AGFiQ U.S. Market Neutral.. 0.00 % 2.53 %

+0.43 (+2.06%)

USD0.16B
XUHC:LSE Xtrackers MSCI USA Health.. 0.00 % 0.12 %

-0.42 (-0.79%)

USD0.69B
IHCU:LSE iShares S&P 500 USD Healt.. 0.00 % 0.18 %

+0.75 (+0.09%)

USD1.69B
ISDU:LSE iShares MSCI USA Islamic .. 0.00 % 0.60 %

-0.50 (-0.91%)

USD0.21B
ISDW:LSE iShares MSCI World Islami.. 0.00 % 0.60 %

-0.17 (-0.44%)

USD0.36B
ISUS:LSE iShares MSCI USA Islamic .. 0.00 % 0.60 %

-4.50 (-0.10%)

USD0.21B
ISWD:LSE iShares MSCI World Islami.. 0.00 % 0.60 %

+12.50 (+0.40%)

USD0.36B
IUHC:LSE iShares S&P 500 USD Healt.. 0.00 % 0.18 %

-0.07 (-0.68%)

USD2.00B
OPEN:LSE iShares Thomson Reuters I.. 0.00 % 0.25 %

-0.04 (-0.56%)

USD0.07B
SXLV:LSE SPDR S&P U.S. Health Care.. 0.00 % 0.15 %

-0.31 (-0.82%)

USD0.40B
WHEA:LSE SPDR® MSCI World Health .. 0.00 % 0.30 %

-0.50 (-0.91%)

USD0.46B
XDWH:LSE Xtrackers MSCI World Heal.. 0.00 % 0.25 %

-0.45 (-0.95%)

USD1.90B
XSHC:LSE Xtrackers MSCI USA Health.. 0.00 % 0.12 %

+2.25 (+0.05%)

USD0.69B
OPEN:F iShares VI Public Limited.. 0.00 % 0.25 %

+0.04 (+0.71%)

USD0.07B
DRDR:LSE iShares Healthcare Innova.. 0.00 % 0.40 %

-2.88 (-0.48%)

USD1.29B
QDVG:F iShares V Public Limited .. 0.00 % 0.18 %

+0.09 (+0.99%)

USD2.00B
XDWH:F Xtrackers (IE) Public Lim.. 0.00 % 0.25 %

+0.14 (+0.32%)

USD1.90B
ZPDH:F SPDR S&P U.S. Health Care.. 0.00 % 0.15 %

+0.18 (+0.49%)

USD0.40B
QDVG:XETRA iShares S&P 500 USD Healt.. 0.00 % 0.18 %

N/A

USD2.00B
XDWH:XETRA Xtrackers MSCI World Heal.. 0.00 % 0.25 %

-0.05 (-0.11%)

USD1.90B
XUHC:XETRA Xtrackers MSCI USA Health.. 0.00 % 0.12 %

-0.01 (-0.01%)

USD0.69B
ZPDH:XETRA SPDR S&P U.S. Health Care.. 0.00 % 0.15 %

+0.01 (+0.03%)

USD0.40B
HIG-U:CA Brompton Global Healthcar.. 0.00 % 0.75 %

N/A

USD0.05B
LONG:CA CI Global Longevity Econo.. 0.00 % 0.96 %

N/A

USD0.06B
ANEW ProShares MSCI Transforma.. 0.00 % 0.45 %

-0.84 (-2.52%)

N/A
CBUF:XETRA iShares MSCI World Health.. 0.00 % 1.00 %

-0.01 (-0.08%)

USD0.40B
HHL-B:CA Harvest Healthcare Leader.. 0.00 % 0.99 %

-0.09 (-1.07%)

N/A
HEAL:LSE iShares Healthcare Innova.. 0.00 % 0.40 %

-0.09 (-1.25%)

USD1.29B
FHI-B:CA CI Health Care Giants Cov.. 0.00 % 0.74 %

N/A

N/A
CURE Direxion Daily Healthcare.. 0.00 % 0.97 %

-5.51 (-5.15%)

USD0.22B
RXL ProShares Ultra Health Ca.. 0.00 % 0.95 %

-3.11 (-3.46%)

USD0.12B
FHLC Fidelity® MSCI Health Ca.. 0.00 % 0.08 %

-1.19 (-1.93%)

USD2.84B
FTCS First Trust Capital Stren.. 0.00 % 0.55 %

-1.12 (-1.57%)

USD8.23B
FUD:CA First Trust AlphaDEX US D.. 0.00 % 0.70 %

N/A

USD0.01B
IHI iShares U.S. Medical Devi.. 0.00 % 0.41 %

-0.92 (-1.80%)

USD6.64B
IXJ iShares Global Healthcare.. 0.00 % 0.43 %

-1.40 (-1.70%)

USD3.56B
IYH iShares U.S. Healthcare E.. 0.00 % 0.41 %

-4.86 (-1.78%)

USD2.87B
JHMH John Hancock Multifactor .. 0.00 % 0.40 %

-0.92 (-1.97%)

USD0.04B
MGV Vanguard Mega Cap Value I.. 0.00 % 0.06 %

-0.85 (-0.87%)

USD5.82B
PJP Invesco Dynamic Pharmaceu.. 0.00 % 0.58 %

-1.47 (-1.94%)

USD0.32B
QDEF FlexShares Quality Divide.. 0.00 % 0.37 %

-0.76 (-1.49%)

USD0.40B
RXD ProShares UltraShort Heal.. 0.00 % 0.95 %

+0.50 (+3.72%)

USD3.39M
RXD ProShares UltraShort Heal.. 0.00 % 0.95 %

+0.50 (+3.72%)

USD3.39M
VHT Vanguard Health Care Inde.. 0.00 % 0.10 %

-4.31 (-1.80%)

USD15.93B
HHL-U:CA Harvest Healthcare Leader.. 0.00 % 0.99 %

-0.16 (-1.88%)

N/A
VIG Vanguard Dividend Appreci.. 0.00 % 0.08 %

-2.51 (-1.72%)

USD76.07B
VTV Vanguard Value Index Fund.. 0.00 % 0.04 %

-1.22 (-0.91%)

USD95.78B
XHC:CA iShares Global Healthcare.. 0.00 % 0.65 %

-1.05 (-1.61%)

USD0.51B
XHE SPDR® S&P Health Care Eq.. 0.00 % 0.35 %

-1.94 (-2.21%)

USD0.40B
XLV Health Care Select Sector.. 0.00 % 0.10 %

-2.26 (-1.74%)

USD39.48B
HHL:CA Healthcare Leaders Income.. 0.00 % 0.99 %

-0.14 (-1.71%)

USD0.33B
MIVG:CA Mackenzie Ivy Global Equi.. 0.00 % 0.84 %

N/A

USD0.03B
LIFE:CA Evolve Global Healthcare .. 0.00 % 0.45 %

-0.38 (-1.71%)

USD0.01B
ACT Enact Holdings Inc 0.00 % 0.99 %

-0.44 (-2.01%)

USD3.57B
FHI:CA CI Health Care Giants Cov.. 0.00 % 0.72 %

-0.18 (-1.55%)

USD0.06B
RWDC Direxion MSCI Defensives .. 0.00 % 0.46 %

N/A

USD7.11M
GDNA Goldman Sachs Human Evolu.. 0.00 % 0.50 %

N/A

USD0.06B
FUD-A:CA First Trust Value Line Di.. 0.00 % 0.70 %

N/A

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Devices)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -23.99% 55% F 31% F
Dividend Return 0.67% 56% F 26% F
Total Return -23.33% 55% F 29% F
Trailing 12 Months  
Capital Gain -8.74% 89% B+ 66% D
Dividend Return 1.57% 63% D 32% F
Total Return -7.17% 93% A 63% D
Trailing 5 Years  
Capital Gain 119.52% 82% B- 92% A-
Dividend Return 14.59% 100% A+ 57% F
Total Return 134.11% 88% B+ 92% A-
Average Annual (5 Year Horizon)  
Capital Gain 22.05% 63% D 84% B
Dividend Return 1.79% 63% D 43% F
Total Return 23.83% 63% D 84% B
Risk Return Profile  
Volatility (Standard Deviation) 13.03% 96% A 75% C
Risk Adjusted Return 182.94% 96% A 100% A+
Market Capitalization 190.99B 100% A+ 99% A+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Devices)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 25.32 76% C 25% F
Price/Book Ratio 5.16 21% F 13% F
Price / Cash Flow Ratio 18.13 45% F 20% F
EV/EBITDA 14.75 72% C- 30% F
Management Effectiveness  
Return on Equity 22.26% 97% A+ 79% C+
Return on Invested Capital 13.83% 93% A 77% C+
Return on Assets 8.56% 97% A+ 87% B+
Debt to Equity Ratio 48.31% 43% F 62% D-
Technical Ratios  
Dividend Yield 1.83% 56% F 30% F
Short Ratio 2.28 66% D 47% F
Short Percent 0.80% 79% C+ 80% B-
Beta 0.72 82% B- 73% C
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Discussions

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.